CARING FOR PATIENTS WITH CANCER:@0.084848:0.038601:0.499679:0.038601:0.499679:0.019343:0.084848:0.019343:0.019121:0.017404:0.014276:0.005315:0.017404:0.020508:0.006515:0.011406:0.020438:0.014276:0.006515:0.012154:0.015492:0.010019:0.005315:0.012606:0.017404:0.010019:0.011712:0.006515:0.022578:0.005315:0.010019:0.016063:0.006515:0.019121:0.017404:0.017404:0.019121:0.012606:0.014276
124:@0.018436:0.038809:0.050045:0.038809:0.050045:0.019212:0.018436:0.019212:0.010536:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
(AML) on the basis of morphology and im-:@0.084848:0.096166:0.475758:0.096166:0.475758:0.080410:0.084848:0.080410:0.007100:0.014239:0.017684:0.008890:0.007100:0.005311:0.012604:0.011738:0.005297:0.006523:0.011738:0.012508:0.005297:0.013123:0.013143:0.007466:0.003848:0.007466:0.005311:0.012604:0.006042:0.005299:0.018049:0.012604:0.005792:0.013123:0.011738:0.012604:0.003848:0.012604:0.012950:0.010314:0.005292:0.013143:0.011738:0.013181:0.005311:0.003848:0.018049:0.006388
munophenotype.  The majority of children :@0.084848:0.112557:0.481105:0.112551:0.481105:0.096795:0.084848:0.096801:0.018049:0.011699:0.011738:0.012604:0.013123:0.011738:0.012508:0.011738:0.012604:0.006523:0.010314:0.013123:0.012508:0.005330:0.006198:0.005215:0.008197:0.011738:0.012508:0.005199:0.018049:0.013143:0.003906:0.012604:0.005792:0.003848:0.006523:0.010314:0.005215:0.012604:0.006042:0.005205:0.012450:0.011738:0.003848:0.003848:0.013181:0.005717:0.012508:0.011738:0.837976
3:@0.248428:0.106932:0.254642:0.106932:0.254642:0.097747:0.248428:0.097747:0.006215
will have a precursor B-cell ALL, known as :@0.084850:0.128942:0.481070:0.128942:0.481070:0.113186:0.084850:0.113186:0.015990:0.003848:0.003848:0.003848:0.006477:0.011738:0.013143:0.010660:0.012508:0.006465:0.013143:0.006465:0.013123:0.005715:0.012508:0.012450:0.011699:0.005792:0.007466:0.012604:0.005792:0.006456:0.011045:0.006388:0.012450:0.012508:0.003848:0.003848:0.006465:0.014239:0.008890:0.008890:0.005330:0.006454:0.009660:0.011738:0.012604:0.015990:0.011738:0.006456:0.013143:0.007466:0.005330
common  ALL.  It is essential to determine :@0.084850:0.145333:0.481101:0.145333:0.481101:0.129577:0.084850:0.129577:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.005330:0.003081:0.014239:0.008890:0.008890:0.005330:0.005330:0.003083:0.004349:0.006523:0.008428:0.003848:0.007466:0.008428:0.012508:0.007466:0.007466:0.012508:0.011738:0.006523:0.003848:0.013143:0.003848:0.008428:0.006523:0.012604:0.008428:0.013181:0.012508:0.006523:0.012508:0.006317:0.018049:0.003848:0.011738:0.012508:0.005330
the ploidy rate, as hyperdiploidy is associ-:@0.084850:0.161724:0.475721:0.161724:0.475721:0.145968:0.084850:0.145968:0.006523:0.011738:0.012508:0.006215:0.013123:0.003848:0.012604:0.003848:0.013181:0.010314:0.006215:0.005792:0.013143:0.006523:0.012508:0.005330:0.006215:0.013143:0.007466:0.006215:0.011738:0.010314:0.013123:0.012508:0.005677:0.013181:0.003848:0.013123:0.003848:0.012604:0.003848:0.013181:0.010314:0.006215:0.003848:0.007466:0.006215:0.013143:0.007466:0.007466:0.012604:0.012450:0.003848:0.006388
ated with a good prognosis. This classifica-:@0.084850:0.178115:0.475759:0.178115:0.475759:0.162359:0.084850:0.162359:0.013143:0.006523:0.012508:0.013181:0.004884:0.015990:0.003848:0.006523:0.011738:0.004880:0.013143:0.004886:0.012950:0.012604:0.012592:0.013181:0.004886:0.013123:0.005715:0.012604:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.005330:0.004878:0.008197:0.011738:0.003848:0.007466:0.004891:0.012450:0.003848:0.013143:0.007466:0.007466:0.003848:0.004686:0.004686:0.012450:0.013156:0.006388
tion  has implications for  both  treatment :@0.084850:0.194506:0.481097:0.194506:0.481097:0.178750:0.084850:0.178750:0.006523:0.003848:0.012604:0.011738:0.005330:0.005009:0.011738:0.013143:0.007466:0.010352:0.003848:0.018049:0.013123:0.003848:0.003848:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.010352:0.006042:0.012604:0.005792:0.005330:0.005007:0.013123:0.012604:0.006523:0.011738:0.005330:0.005007:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330
protocol  and prognosis. For this reason, :@0.084850:0.210897:0.481097:0.210897:0.481097:0.195141:0.084850:0.195141:0.013123:0.005715:0.012604:0.006523:0.012604:0.012450:0.012604:0.003848:0.005330:0.005609:0.013143:0.011738:0.013181:0.010949:0.013123:0.005715:0.012604:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.005330:0.010949:0.009333:0.012604:0.005792:0.010949:0.006523:0.011738:0.003848:0.007466:0.010949:0.005713:0.012508:0.013143:0.007466:0.012604:0.011738:0.005330:0.005330
the  child with suspected ALL should be :@0.084850:0.227288:0.481099:0.227288:0.481099:0.211532:0.084850:0.211532:0.006523:0.011738:0.012508:0.005330:0.004974:0.012450:0.011738:0.003848:0.003848:0.013181:0.010314:0.015990:0.003848:0.006523:0.011738:0.010314:0.007466:0.011699:0.007466:0.013123:0.012508:0.012450:0.006523:0.012508:0.013181:0.010314:0.014239:0.008890:0.008890:0.010314:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.010314:0.013123:0.012508:0.005330
referred to  a specialised  paediatric on-:@0.084850:0.243679:0.475771:0.243679:0.475771:0.227923:0.084850:0.227923:0.005713:0.012508:0.006042:0.012508:0.005792:0.005703:0.012508:0.013181:0.010603:0.006523:0.012604:0.005330:0.005263:0.013143:0.010603:0.007466:0.013123:0.012508:0.012450:0.003848:0.013143:0.003848:0.003848:0.007466:0.012508:0.013181:0.005330:0.005288:0.013123:0.013143:0.012508:0.013181:0.003848:0.013143:0.006523:0.005792:0.003848:0.012450:0.010603:0.012604:0.011738:0.006388
cology unit for the necessary diagnostic :@0.084850:0.260070:0.481089:0.260070:0.481089:0.244314:0.084850:0.244314:0.012450:0.012604:0.003848:0.012604:0.012950:0.010314:0.009198:0.011699:0.011738:0.003848:0.006523:0.009198:0.006042:0.012604:0.005792:0.009198:0.006523:0.011738:0.012508:0.009198:0.011738:0.012508:0.012450:0.012508:0.007466:0.007466:0.013143:0.005792:0.010314:0.009198:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.006523:0.003848:0.012450:0.005330
investigations. Molecular- and cyoge-:@0.084850:0.276461:0.475759:0.276461:0.475759:0.260705:0.084850:0.260705:0.003848:0.011738:0.010660:0.012508:0.007466:0.006523:0.003848:0.012950:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330:0.018492:0.017684:0.012604:0.003848:0.012508:0.012450:0.011699:0.003848:0.013143:0.005792:0.006388:0.018492:0.013143:0.011738:0.013181:0.018492:0.012450:0.010314:0.012604:0.012950:0.012508:0.006388
netics  are  done  to  assist  in  risk  stratifica-:@0.084850:0.292852:0.475765:0.292852:0.475765:0.277096:0.084850:0.277096:0.011738:0.012508:0.006523:0.003848:0.012450:0.007466:0.005330:0.003662:0.013143:0.005711:0.012508:0.005330:0.003660:0.013181:0.012604:0.011738:0.012508:0.005330:0.003658:0.006523:0.012604:0.005330:0.003656:0.013143:0.007466:0.007466:0.003848:0.007466:0.006523:0.005330:0.003675:0.003848:0.011738:0.005330:0.003662:0.005792:0.003848:0.007466:0.009660:0.005330:0.003668:0.007466:0.006523:0.005792:0.013143:0.006523:0.003848:0.004686:0.004686:0.012450:0.013143:0.006388
tion,  which  again determines intensity of :@0.084850:0.309242:0.481109:0.309242:0.481109:0.293487:0.084850:0.293487:0.006523:0.003848:0.012604:0.011738:0.005330:0.005330:0.003160:0.015990:0.011738:0.003848:0.012450:0.011738:0.005330:0.003165:0.013143:0.012950:0.013143:0.003848:0.011738:0.008505:0.013181:0.012508:0.006523:0.012508:0.006317:0.018049:0.003848:0.011738:0.012508:0.007466:0.008505:0.003848:0.011738:0.006523:0.012508:0.011738:0.007466:0.003848:0.006523:0.010314:0.008505:0.012604:0.006042:0.005330
onco-chemotherapy.  The  most common :@0.084850:0.325633:0.481107:0.325633:0.481107:0.309877:0.084850:0.309877:0.012604:0.011738:0.012450:0.012604:0.006388:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.005330:0.003569:0.008197:0.011738:0.012508:0.005330:0.003587:0.018049:0.012604:0.007466:0.006523:0.008928:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.005330
translocation is t(12;21), associated with a :@0.084850:0.342024:0.481084:0.342024:0.481084:0.326268:0.084850:0.326268:0.006523:0.005792:0.013143:0.011738:0.007466:0.003848:0.012604:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.006104:0.003848:0.007466:0.006119:0.006523:0.007100:0.010660:0.010660:0.005330:0.010660:0.010660:0.007100:0.005330:0.006119:0.013143:0.007466:0.007466:0.012604:0.012450:0.003848:0.013143:0.006523:0.012508:0.013181:0.006119:0.015990:0.003848:0.006523:0.011738:0.006109:0.013143:0.005330
favourable prognosis, followed by t(1;19).:@0.084850:0.358415:0.469003:0.358415:0.469003:0.342659:0.084850:0.342659:0.006042:0.013143:0.010660:0.012604:0.011699:0.005792:0.013143:0.013123:0.003848:0.012508:0.005330:0.013123:0.005713:0.012604:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.005330:0.005330:0.006042:0.012604:0.003848:0.003848:0.012604:0.015990:0.012508:0.013181:0.005330:0.013123:0.010314:0.005330:0.006523:0.007100:0.010660:0.005330:0.010660:0.010660:0.007100:0.005330
TREATMENT AND OUTCOME:@0.084848:0.391431:0.361511:0.391431:0.361511:0.373616:0.084848:0.373616:0.008980:0.012401:0.011118:0.015822:0.008980:0.019242:0.011118:0.015822:0.008980:0.005987:0.015822:0.015822:0.014966:0.005987:0.017960:0.013683:0.008980:0.016677:0.017960:0.019242:0.011118
Current event-free survival rates for ALL in :@0.084848:0.408963:0.481092:0.408963:0.481092:0.393207:0.084848:0.393207:0.015644:0.011699:0.005792:0.005705:0.012508:0.011738:0.006523:0.006600:0.012508:0.010660:0.012508:0.011738:0.006523:0.006388:0.006042:0.005707:0.012508:0.012508:0.006600:0.007466:0.011699:0.005792:0.010660:0.003848:0.010660:0.013143:0.003848:0.006621:0.005792:0.013143:0.006523:0.012508:0.007466:0.006600:0.006042:0.012604:0.005792:0.006600:0.014239:0.008890:0.008890:0.006600:0.003848:0.011738:0.005330
children is more than 80% in high-income :@0.084848:0.425354:0.481103:0.425354:0.481103:0.409598:0.084848:0.409598:0.012450:0.011738:0.003848:0.003848:0.013181:0.005719:0.012508:0.011738:0.007141:0.003848:0.007466:0.007158:0.018049:0.012604:0.005707:0.012508:0.007145:0.006523:0.011738:0.013143:0.011738:0.007143:0.010660:0.010660:0.014913:0.007158:0.003848:0.011738:0.007147:0.011738:0.003848:0.012950:0.011738:0.006388:0.003848:0.011738:0.012450:0.012604:0.018049:0.012508:0.005330
countries.  This is  because of multi-agent :@0.084848:0.441745:0.481071:0.441734:0.481071:0.425978:0.084848:0.425989:0.012450:0.012604:0.011699:0.011738:0.006523:0.005792:0.003848:0.012508:0.007466:0.005330:0.006204:0.008678:0.008197:0.011738:0.003848:0.007466:0.008678:0.003848:0.007466:0.005330:0.003362:0.013123:0.012508:0.012450:0.013143:0.011699:0.007466:0.012508:0.008678:0.012604:0.006042:0.008678:0.018049:0.011699:0.003848:0.006523:0.003848:0.006388:0.013143:0.012950:0.012508:0.011738:0.006523:0.359199
3:@0.174794:0.436115:0.181008:0.436115:0.181008:0.426930:0.174794:0.426930:0.006215
combination onco-chemotherapy, im-:@0.084856:0.458125:0.475758:0.458125:0.475758:0.442369:0.084856:0.442369:0.012450:0.012604:0.018049:0.013123:0.003848:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.020686:0.012604:0.011738:0.012450:0.012604:0.006388:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011711:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.020686:0.003848:0.018049:0.006388
proved supportive care and optimal in-:@0.084856:0.474516:0.475785:0.474516:0.475785:0.458760:0.084856:0.458760:0.013123:0.005715:0.012604:0.010660:0.012508:0.013181:0.010160:0.007466:0.011699:0.013123:0.013123:0.012604:0.005792:0.006523:0.003848:0.010660:0.012508:0.010160:0.012450:0.013143:0.005715:0.012508:0.010160:0.013143:0.011738:0.013181:0.010160:0.012604:0.013123:0.006523:0.003848:0.018049:0.013143:0.003848:0.010160:0.003848:0.011738:0.006388
dividual  medicine-dosing. The treatment :@0.084856:0.490907:0.481109:0.490907:0.481109:0.475151:0.084856:0.475151:0.013181:0.003848:0.010660:0.003848:0.013181:0.011699:0.013143:0.003848:0.005330:0.004753:0.018049:0.012508:0.013181:0.003848:0.012450:0.003848:0.011738:0.012508:0.006388:0.013181:0.012604:0.007466:0.003848:0.011738:0.012950:0.005330:0.010064:0.008197:0.011738:0.012508:0.010064:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330
protocol  is decided according to risk :@0.084856:0.507298:0.481080:0.507298:0.481080:0.491542:0.084856:0.491542:0.013123:0.005715:0.012604:0.006523:0.012604:0.012450:0.012604:0.003848:0.005330:0.009727:0.003848:0.007466:0.015067:0.013181:0.012508:0.012450:0.003848:0.013181:0.012508:0.013181:0.015067:0.013143:0.012450:0.012450:0.012604:0.005671:0.013181:0.003848:0.011738:0.012950:0.015067:0.006523:0.012604:0.015067:0.005792:0.003848:0.007466:0.009660:0.005330
stratification and appropriate for cell type :@0.084856:0.523689:0.481100:0.523689:0.481100:0.507933:0.084856:0.507933:0.007466:0.006523:0.005792:0.013143:0.006523:0.003848:0.004686:0.004686:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.005528:0.013143:0.011738:0.013181:0.005536:0.013143:0.013123:0.013123:0.005721:0.012604:0.013123:0.005792:0.003848:0.013143:0.006523:0.012508:0.005536:0.006042:0.012604:0.005792:0.005528:0.012450:0.012508:0.003848:0.003848:0.005540:0.006523:0.010314:0.013123:0.012508:0.005330
(either  T-  or  B-cell  ALL)  with  risk  stratifica-:@0.084856:0.540080:0.475766:0.540080:0.475766:0.524324:0.084856:0.524324:0.007100:0.012508:0.003848:0.006523:0.011738:0.012508:0.005792:0.005330:0.003121:0.008197:0.006388:0.005330:0.003123:0.012604:0.005792:0.005330:0.003119:0.011045:0.006388:0.012450:0.012508:0.003848:0.003848:0.005330:0.003135:0.014239:0.008890:0.008890:0.007100:0.005330:0.003121:0.015990:0.003848:0.006523:0.011738:0.005330:0.003127:0.005792:0.003848:0.007466:0.009660:0.005330:0.003133:0.007466:0.006523:0.005792:0.013143:0.006523:0.003848:0.004686:0.004686:0.012450:0.013143:0.006388
tion and consists of an induction phase, a :@0.084856:0.556471:0.481077:0.556471:0.481077:0.540715:0.084856:0.540715:0.006523:0.003848:0.012604:0.011738:0.005850:0.013143:0.011738:0.013181:0.005850:0.012450:0.012604:0.011738:0.007466:0.003848:0.007466:0.006523:0.007466:0.005850:0.012604:0.006042:0.005850:0.013143:0.011738:0.005850:0.003848:0.011738:0.013181:0.011699:0.012450:0.006523:0.003848:0.012604:0.011738:0.005850:0.013123:0.011738:0.013143:0.007466:0.012508:0.005330:0.005850:0.013143:0.005330
post-induction  phase and maintenance :@0.084856:0.572862:0.481105:0.572862:0.481105:0.557106:0.084856:0.557106:0.013123:0.012604:0.007466:0.006523:0.006388:0.003848:0.011738:0.013181:0.011699:0.012450:0.006523:0.003848:0.012604:0.011738:0.005330:0.005917:0.013123:0.011738:0.013143:0.007466:0.012508:0.011257:0.013143:0.011738:0.013181:0.011257:0.018049:0.013143:0.003848:0.011738:0.006523:0.012508:0.011738:0.013143:0.011738:0.012450:0.012508:0.005330
therapy  for  two  years,  as well as central :@0.084856:0.589253:0.481121:0.589253:0.481121:0.573497:0.084856:0.573497:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.003273:0.006042:0.012604:0.005792:0.005330:0.003269:0.006523:0.015990:0.012604:0.005330:0.003271:0.010314:0.012508:0.013143:0.005792:0.007466:0.005330:0.005330:0.003277:0.013143:0.007466:0.008621:0.015990:0.012508:0.003848:0.003848:0.008621:0.013143:0.007466:0.008621:0.012450:0.012508:0.011738:0.006523:0.005792:0.013143:0.003848:0.005330
nervous system (CNS) preventive therapy. :@0.084856:0.605644:0.481111:0.605644:0.481111:0.589888:0.084856:0.589888:0.011738:0.012508:0.005792:0.010660:0.012604:0.011699:0.007466:0.006042:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.006050:0.007100:0.015644:0.014239:0.009583:0.007100:0.006050:0.013123:0.005715:0.012508:0.010660:0.012508:0.011738:0.006523:0.003848:0.010660:0.012508:0.006061:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.005330
A stem cell transplant may be indicated, :@0.084856:0.622034:0.481077:0.622034:0.481077:0.606279:0.084856:0.606279:0.014239:0.007254:0.007466:0.006523:0.012508:0.018049:0.007254:0.012450:0.012508:0.003848:0.003848:0.007254:0.006523:0.005792:0.013143:0.011738:0.007466:0.013123:0.003848:0.013143:0.011738:0.006523:0.007254:0.018049:0.013143:0.010314:0.007254:0.013123:0.012508:0.007254:0.003848:0.011738:0.013181:0.003848:0.012450:0.013143:0.006523:0.012508:0.013181:0.005330:0.005330
especially for relapses.:@0.084856:0.638425:0.294117:0.638425:0.294117:0.622669:0.084856:0.622669:0.012508:0.007466:0.013123:0.012508:0.012450:0.003848:0.013143:0.003848:0.003848:0.010314:0.005330:0.006042:0.012604:0.005792:0.005330:0.005715:0.012508:0.003848:0.013143:0.013123:0.007466:0.012508:0.007466:0.005330
BRAIN TUMOURS:@0.084848:0.671780:0.266881:0.671780:0.266881:0.652183:0.084848:0.652183:0.013641:0.013641:0.017404:0.006585:0.017404:0.006585:0.009878:0.015052:0.021167:0.019756:0.015052:0.013641:0.012230
Brain tumours are the second most com-:@0.084848:0.690459:0.475781:0.690459:0.475781:0.674703:0.084848:0.674703:0.011045:0.005792:0.013143:0.003848:0.011738:0.007562:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.007549:0.013143:0.005711:0.012508:0.007553:0.006523:0.011738:0.012508:0.007547:0.007466:0.012508:0.012450:0.012604:0.011738:0.013181:0.007562:0.018049:0.012604:0.007466:0.006523:0.007551:0.012450:0.012604:0.018049:0.006388
mon  childhood  cancer  and tumours  are :@0.084848:0.706850:0.481094:0.706850:0.481094:0.691094:0.084848:0.691094:0.018049:0.012604:0.011738:0.005330:0.003067:0.012450:0.011738:0.003848:0.003848:0.013181:0.011738:0.012604:0.012604:0.013181:0.005330:0.003067:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330:0.003067:0.013143:0.011738:0.013181:0.008409:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005330:0.003063:0.013143:0.005713:0.012508:0.005330
heterogenous in pathology.:@0.084848:0.723241:0.346301:0.723241:0.346301:0.707485:0.084848:0.707485:0.011738:0.012508:0.006523:0.012508:0.005703:0.012604:0.012950:0.012508:0.011738:0.012604:0.011699:0.007466:0.006560:0.003848:0.011738:0.006581:0.013123:0.013143:0.006523:0.011738:0.012604:0.003848:0.012604:0.012950:0.010314:0.005330
8,9 :@0.346288:0.717611:0.364933:0.717611:0.364933:0.708426:0.346288:0.708426:0.006215:0.003107:0.006215:0.003107
More males :@0.365661:0.723230:0.481088:0.723230:0.481088:0.707474:0.365661:0.707474:0.017684:0.012604:0.005707:0.012508:0.006581:0.018049:0.013143:0.003848:0.012508:0.007466:0.005330
than females are affected. The WHO clas-:@0.084856:0.739621:0.475774:0.739621:0.475774:0.723865:0.084856:0.723865:0.006523:0.011738:0.013143:0.011738:0.005159:0.006042:0.012508:0.018049:0.013143:0.003848:0.012508:0.007466:0.005176:0.013143:0.005713:0.012508:0.005163:0.013143:0.006100:0.006042:0.012508:0.012450:0.006523:0.012508:0.013181:0.005330:0.005155:0.008197:0.011738:0.012508:0.005161:0.018473:0.013143:0.016722:0.005176:0.012450:0.003848:0.013143:0.007466:0.006388
sification system classifies brain tumours by :@0.084856:0.756012:0.481083:0.756012:0.481083:0.740256:0.084856:0.740256:0.007466:0.003848:0.004686:0.004686:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.005018:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.005018:0.012450:0.003848:0.013143:0.007466:0.007466:0.003848:0.004686:0.004686:0.012508:0.007466:0.005034:0.013123:0.005792:0.013143:0.003848:0.011738:0.005018:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005009:0.013123:0.010314:0.005330
histology type, site and degree of malig-:@0.084856:0.772403:0.475722:0.772403:0.475722:0.756647:0.084856:0.756647:0.011738:0.003848:0.007466:0.006523:0.012604:0.003848:0.012604:0.012950:0.010314:0.007755:0.006523:0.010314:0.013123:0.012508:0.005330:0.007755:0.007466:0.003848:0.006523:0.012508:0.007755:0.013143:0.011738:0.013181:0.007755:0.013181:0.012508:0.012950:0.005709:0.012508:0.012508:0.007755:0.012604:0.006042:0.007755:0.018049:0.013143:0.003848:0.003848:0.012950:0.006388
nancy. During childhood, the majority will :@0.084856:0.788794:0.481090:0.788794:0.481090:0.773038:0.084856:0.773038:0.011738:0.013143:0.011738:0.012450:0.010314:0.005330:0.006567:0.014316:0.011699:0.005792:0.003848:0.011738:0.012950:0.006566:0.012450:0.011738:0.003848:0.003848:0.013181:0.011738:0.012604:0.012604:0.013181:0.005330:0.006566:0.006523:0.011738:0.012508:0.006571:0.018049:0.013143:0.003906:0.012604:0.005792:0.003848:0.006523:0.010314:0.006571:0.015990:0.003848:0.003848:0.003848:0.005330
be located infratentorially in either  the :@0.084856:0.805185:0.481106:0.805185:0.481106:0.789429:0.084856:0.789429:0.013123:0.012508:0.012103:0.003848:0.012604:0.012450:0.013143:0.006523:0.012508:0.013181:0.012103:0.003848:0.011738:0.006042:0.005792:0.013143:0.006523:0.012508:0.011738:0.006523:0.012604:0.005792:0.003848:0.013143:0.003848:0.003848:0.010314:0.012103:0.003848:0.011738:0.012103:0.012508:0.003848:0.006523:0.011738:0.012508:0.005792:0.005330:0.006764:0.006523:0.011738:0.012508:0.005330
cerebellum or brainstem, while the first two :@0.084856:0.821576:0.481094:0.821576:0.481094:0.805820:0.084856:0.805820:0.012450:0.012508:0.005709:0.012508:0.013123:0.012508:0.003848:0.003848:0.011699:0.018049:0.004305:0.012604:0.005792:0.004289:0.013123:0.005792:0.013143:0.003848:0.011738:0.007466:0.006523:0.012508:0.018049:0.005330:0.004295:0.015990:0.011738:0.003848:0.003848:0.012508:0.004299:0.006523:0.011738:0.012508:0.004291:0.004686:0.004686:0.005792:0.007466:0.006523:0.004291:0.006523:0.015990:0.012604:0.005330
years of life (astrocytoma) and late ado-:@0.084856:0.837967:0.475781:0.837967:0.475781:0.822211:0.084856:0.822211:0.010314:0.012508:0.013143:0.005792:0.007466:0.007447:0.012604:0.006042:0.007447:0.003848:0.003848:0.006042:0.012508:0.007447:0.007100:0.013143:0.007466:0.006523:0.005711:0.012604:0.012450:0.010314:0.006523:0.012604:0.018049:0.013143:0.007100:0.007447:0.013143:0.011738:0.013181:0.007447:0.003848:0.013143:0.006523:0.012508:0.007447:0.013143:0.013181:0.012604:0.006388
lescence are associated with supraten-:@0.084856:0.854358:0.475766:0.854358:0.475766:0.838602:0.084856:0.838602:0.003848:0.012508:0.007466:0.012450:0.012508:0.011738:0.012450:0.012508:0.011315:0.013143:0.005715:0.012508:0.011315:0.013143:0.007466:0.007466:0.012604:0.012450:0.003848:0.013143:0.006523:0.012508:0.013181:0.011315:0.015990:0.003848:0.006523:0.011738:0.011315:0.007466:0.011699:0.013123:0.005792:0.013143:0.006523:0.012508:0.011738:0.006388
torial tumours. Common  brain tumours :@0.084856:0.870749:0.481127:0.870749:0.481127:0.854993:0.084856:0.854993:0.006523:0.012604:0.005792:0.003848:0.013143:0.003848:0.013970:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005321:0.013970:0.015644:0.012604:0.018049:0.018049:0.012604:0.011738:0.005330:0.008623:0.013123:0.005792:0.013143:0.003848:0.011738:0.013970:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005330
include pilocytic astrocytoma, medullo-:@0.084856:0.887140:0.475776:0.887140:0.475776:0.871384:0.084856:0.871384:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.012219:0.013123:0.003848:0.003848:0.012604:0.012450:0.010314:0.006523:0.003848:0.012450:0.012219:0.013143:0.007466:0.006523:0.005715:0.012604:0.012450:0.010314:0.006523:0.012604:0.018040:0.013143:0.005330:0.012219:0.018049:0.012508:0.013181:0.011699:0.003848:0.003848:0.012604:0.006388
blastoma, ependymoma,  and supraten-:@0.084856:0.903531:0.475776:0.903531:0.475776:0.887775:0.084856:0.887775:0.013123:0.003848:0.013143:0.007466:0.006523:0.012604:0.018049:0.013143:0.005330:0.010237:0.012508:0.013123:0.012508:0.011738:0.013181:0.010314:0.018049:0.012604:0.018049:0.013143:0.005330:0.005330:0.004897:0.013143:0.011738:0.013181:0.010237:0.007466:0.011699:0.013123:0.005792:0.013143:0.006523:0.012508:0.011738:0.006388
torial primitive neuro-ectodermal tumours :@0.084856:0.919922:0.481104:0.919922:0.481104:0.904166:0.084856:0.904166:0.006523:0.012604:0.005792:0.003848:0.013143:0.003848:0.007120:0.013123:0.005792:0.003848:0.018049:0.003848:0.006523:0.003848:0.010660:0.012508:0.007120:0.011738:0.012508:0.011699:0.005705:0.012604:0.006388:0.012508:0.012450:0.006523:0.012604:0.013181:0.012508:0.006310:0.018049:0.013143:0.003848:0.007120:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005330
(PNET).  Medulloblastoma and PNET  are :@0.084856:0.936312:0.481092:0.936312:0.481092:0.920557:0.084856:0.920557:0.007100:0.011392:0.014239:0.010314:0.008197:0.007100:0.005330:0.005330:0.007264:0.017684:0.012508:0.013181:0.011699:0.003848:0.003848:0.012604:0.013123:0.003848:0.013143:0.007466:0.006523:0.012604:0.018049:0.013143:0.012604:0.013143:0.011738:0.013181:0.012604:0.011392:0.014239:0.010314:0.008197:0.005330:0.007262:0.013143:0.005713:0.012508:0.005330
both embryonal tumours. A small number :@0.524257:0.096234:0.920485:0.096166:0.920485:0.080410:0.524257:0.080478:0.013123:0.012604:0.006523:0.011738:0.005871:0.012508:0.018049:0.013123:0.005792:0.010314:0.012604:0.011738:0.013143:0.003848:0.005888:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005330:0.009604:0.014239:0.005873:0.007466:0.018049:0.013143:0.003848:0.003848:0.005888:0.011738:0.011699:0.018049:0.013123:0.012508:0.005792:0.422430
9 :@0.760246:0.090547:0.769569:0.090547:0.769569:0.081361:0.760246:0.081361:0.006215:0.003107
of tumours will be associated with cancer :@0.524242:0.112557:0.920500:0.112557:0.920500:0.096801:0.524242:0.096801:0.012604:0.006042:0.006121:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.006123:0.015990:0.003848:0.003848:0.003848:0.006138:0.013123:0.012508:0.006127:0.013143:0.007466:0.007466:0.012604:0.012450:0.003848:0.013143:0.006523:0.012508:0.013181:0.006138:0.015990:0.003848:0.006523:0.011738:0.006125:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330
predisposition syndromes  such  as Li-Frau-:@0.524242:0.128947:0.915161:0.128947:0.915161:0.113192:0.524242:0.113192:0.013123:0.005715:0.012508:0.013181:0.003848:0.007466:0.013123:0.012604:0.007466:0.003848:0.006523:0.003848:0.012604:0.011738:0.008717:0.007466:0.010314:0.011738:0.013181:0.005715:0.012604:0.018049:0.012508:0.007466:0.005330:0.003371:0.007466:0.011699:0.012450:0.011738:0.005330:0.003373:0.013143:0.007466:0.008717:0.008890:0.003848:0.006388:0.009333:0.005792:0.013143:0.011699:0.006388
meni’s syndrome, neurofibromatosis types, :@0.524242:0.145338:0.920487:0.145338:0.920487:0.129582:0.524242:0.129582:0.018049:0.012508:0.011738:0.003848:0.006754:0.007466:0.004743:0.007466:0.010314:0.011738:0.013181:0.005717:0.012604:0.018049:0.012508:0.005330:0.004734:0.011738:0.012508:0.011699:0.005705:0.012604:0.004686:0.004686:0.013123:0.005707:0.012604:0.018049:0.013143:0.006523:0.012604:0.007466:0.003848:0.007466:0.004745:0.006523:0.010314:0.013123:0.012508:0.007466:0.005330:0.005330
tuberous sclerosis 1 and 2 and Gorlin’s syn-:@0.524242:0.161729:0.915170:0.161729:0.915170:0.145973:0.524242:0.145973:0.006523:0.011699:0.013123:0.012508:0.005709:0.012604:0.011699:0.007466:0.004855:0.007466:0.012450:0.003848:0.012508:0.005717:0.012604:0.007466:0.003848:0.007466:0.004868:0.010660:0.004868:0.013143:0.011738:0.013181:0.004857:0.010660:0.004868:0.013143:0.011738:0.013181:0.004859:0.016779:0.012604:0.005792:0.003848:0.003848:0.011738:0.006754:0.007466:0.004868:0.007466:0.010314:0.011738:0.006388
drome.  The clinical  symptoms and signs :@0.524242:0.178120:0.920467:0.178094:0.920467:0.162338:0.524242:0.162364:0.013181:0.005713:0.012604:0.018049:0.012508:0.005330:0.006209:0.008909:0.008197:0.011738:0.012508:0.008909:0.012450:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.005330:0.003593:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.007466:0.008909:0.013143:0.011738:0.013181:0.008909:0.007466:0.003848:0.012950:0.011738:0.007466:0.303279
8:@0.591618:0.172475:0.597833:0.172475:0.597833:0.163289:0.591618:0.163289:0.006215
include  headaches  with  or  without  early :@0.524233:0.194485:0.920467:0.194485:0.920467:0.178729:0.524233:0.178729:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.005330:0.003221:0.011738:0.012508:0.013143:0.013181:0.013143:0.012450:0.011738:0.012508:0.007466:0.005330:0.003217:0.015990:0.003848:0.006523:0.011738:0.005330:0.003221:0.012604:0.005792:0.005330:0.003212:0.015990:0.003848:0.006523:0.011738:0.012604:0.011699:0.006523:0.005330:0.003210:0.012508:0.013143:0.005792:0.003848:0.010314:0.005330
morning vomiting (due to raised intracra-:@0.524233:0.210876:0.915154:0.210876:0.915154:0.195120:0.524233:0.195120:0.018049:0.012604:0.006188:0.011738:0.003848:0.011738:0.012950:0.007043:0.010660:0.012604:0.018049:0.003848:0.006523:0.003848:0.011738:0.012950:0.007043:0.007100:0.013181:0.011699:0.012508:0.007043:0.006523:0.012604:0.007043:0.005792:0.013143:0.003848:0.007466:0.012508:0.013181:0.007043:0.003848:0.011738:0.006523:0.005792:0.013143:0.012450:0.005792:0.013143:0.006388
nial pressure),  cerebellar ataxia, cranial :@0.524233:0.227267:0.920481:0.227267:0.920481:0.211511:0.524233:0.211511:0.011738:0.003848:0.013143:0.003848:0.011488:0.013123:0.005715:0.012508:0.007466:0.007466:0.011699:0.005719:0.012508:0.007100:0.005330:0.005330:0.006146:0.012450:0.012508:0.005711:0.012508:0.013123:0.012508:0.003848:0.003848:0.013143:0.005792:0.011488:0.013143:0.006523:0.013143:0.009236:0.003848:0.013143:0.005330:0.011488:0.012450:0.005792:0.013143:0.011738:0.003848:0.013143:0.003848:0.005330
nerve palsies, pyramidal tract signs and/or :@0.524233:0.243658:0.920454:0.243658:0.920454:0.227902:0.524233:0.227902:0.011738:0.012508:0.005792:0.010660:0.012508:0.004743:0.013123:0.013143:0.003848:0.007466:0.003848:0.012508:0.007466:0.005330:0.004753:0.013123:0.010314:0.005792:0.013143:0.018049:0.003848:0.013181:0.013143:0.003848:0.004753:0.006523:0.005792:0.013143:0.012450:0.006523:0.004743:0.007466:0.003848:0.012950:0.011738:0.007466:0.004753:0.013143:0.011738:0.013181:0.008409:0.012604:0.005792:0.005330
change in temperament.  Correct diag-:@0.524233:0.260049:0.915147:0.260022:0.915147:0.244266:0.524233:0.244293:0.012450:0.011738:0.013143:0.011738:0.012950:0.012508:0.007179:0.003848:0.011738:0.007197:0.006523:0.012508:0.018049:0.013123:0.012508:0.005792:0.013143:0.018049:0.012508:0.011738:0.006523:0.005330:0.015525:0.007187:0.015644:0.012604:0.005792:0.005705:0.012508:0.012450:0.006523:0.007183:0.013181:0.003848:0.013143:0.012950:0.190490
8,9:@0.764500:0.254403:0.780037:0.254403:0.780037:0.245218:0.764500:0.245218:0.006215:0.003107:0.006215
nosis is extremely important to ensure the :@0.524251:0.276413:0.920525:0.276413:0.920525:0.260657:0.524251:0.260657:0.011738:0.012604:0.007466:0.003848:0.007466:0.007081:0.003848:0.007466:0.007081:0.012508:0.009236:0.006523:0.005707:0.012508:0.018049:0.012508:0.003848:0.010314:0.007081:0.003848:0.018049:0.013123:0.012604:0.005792:0.006523:0.013143:0.011738:0.006523:0.007060:0.006523:0.012604:0.007068:0.012508:0.011738:0.007466:0.011699:0.005709:0.012508:0.007068:0.006523:0.011738:0.012508:0.005330
most appropriate treatment and is made :@0.524251:0.292804:0.920492:0.292804:0.920492:0.277048:0.524251:0.277048:0.018049:0.012604:0.007466:0.006523:0.006831:0.013143:0.013123:0.013123:0.005715:0.012604:0.013123:0.005792:0.003848:0.013143:0.006523:0.012508:0.006831:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.006820:0.013143:0.011738:0.013181:0.006831:0.003848:0.007466:0.006831:0.018049:0.013143:0.013181:0.012508:0.005330
after magnetic resonance imaging and :@0.524251:0.309195:0.920508:0.309195:0.920508:0.293439:0.524251:0.293439:0.013143:0.006042:0.006523:0.012508:0.005792:0.010314:0.018049:0.013143:0.012950:0.011738:0.012508:0.006523:0.003848:0.012450:0.010314:0.005713:0.012508:0.007466:0.012604:0.011738:0.013143:0.011738:0.012450:0.012508:0.010314:0.003848:0.018049:0.013143:0.012950:0.003848:0.011738:0.012950:0.010314:0.013143:0.011738:0.013181:0.005330
biopsy  or surgical  excision (if possible).  :@0.524251:0.325586:0.920481:0.325565:0.920481:0.309809:0.524251:0.309830:0.013123:0.003848:0.012604:0.013123:0.007466:0.010314:0.005330:0.006173:0.012604:0.005792:0.011488:0.007466:0.011699:0.005809:0.012950:0.003848:0.012450:0.013143:0.003848:0.005330:0.006173:0.012508:0.009236:0.012450:0.003848:0.007466:0.003848:0.012604:0.011738:0.011488:0.007100:0.003848:0.006042:0.011488:0.013123:0.012604:0.007466:0.007466:0.003848:0.013123:0.003848:0.012508:0.007100:0.005330:0.006235:0.088763
8:@0.908933:0.319946:0.915148:0.319946:0.915148:0.310760:0.908933:0.310760:0.006215
Management  is according to histologi-:@0.524241:0.341956:0.915154:0.341956:0.915154:0.326200:0.524241:0.326200:0.017684:0.013143:0.011738:0.013143:0.012950:0.012508:0.018049:0.012508:0.011738:0.006523:0.005330:0.007320:0.003848:0.007466:0.012662:0.013143:0.012450:0.012450:0.012604:0.005673:0.013181:0.003848:0.011738:0.012950:0.012662:0.006523:0.012604:0.012662:0.011738:0.003848:0.007466:0.006523:0.012604:0.003848:0.012604:0.012950:0.003848:0.006388
cal type, site and degree of malignancy. :@0.524241:0.358347:0.920485:0.358347:0.920485:0.342591:0.524241:0.342591:0.012450:0.013143:0.003848:0.006793:0.006523:0.010314:0.013123:0.012508:0.005330:0.006781:0.007466:0.003848:0.006523:0.012508:0.006793:0.013143:0.011738:0.013181:0.006783:0.013181:0.012508:0.012950:0.005709:0.012508:0.012508:0.006779:0.012604:0.006042:0.006779:0.018049:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.012450:0.010314:0.005330:0.005330
Treatment usually  involves  a multimodal :@0.524241:0.374738:0.920471:0.374738:0.920471:0.358982:0.524241:0.358982:0.007620:0.005713:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.010814:0.011699:0.007466:0.011699:0.013143:0.003848:0.003848:0.010314:0.005330:0.005499:0.003848:0.011738:0.010660:0.012604:0.003848:0.010660:0.012508:0.007466:0.005330:0.005499:0.013143:0.010814:0.018049:0.011699:0.003848:0.006523:0.003848:0.018049:0.012604:0.013181:0.013143:0.003848:0.005330
approach,  combining surgery, radiother-:@0.524241:0.391129:0.915151:0.391129:0.915151:0.375373:0.524241:0.375373:0.013143:0.013123:0.013123:0.005719:0.012604:0.013143:0.012450:0.011738:0.005330:0.005330:0.003608:0.012450:0.012604:0.018049:0.013123:0.003848:0.011738:0.003848:0.011738:0.012950:0.008948:0.007466:0.011699:0.005807:0.012950:0.012508:0.005782:0.010314:0.005330:0.008948:0.005792:0.013143:0.013181:0.003848:0.012604:0.006523:0.011738:0.012508:0.005773:0.006388
apy with or without onco-chemotherapy. :@0.524241:0.407519:0.920494:0.407519:0.920494:0.391764:0.524241:0.391764:0.013143:0.013123:0.010314:0.006843:0.015990:0.003848:0.006523:0.011738:0.006831:0.012604:0.005792:0.006831:0.015990:0.003848:0.006523:0.011738:0.012604:0.011699:0.006523:0.006831:0.012604:0.011738:0.012450:0.012604:0.006388:0.012450:0.011738:0.012490:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.005330
There is an improved survival rate if the tu-:@0.524241:0.423910:0.915156:0.423910:0.915156:0.408154:0.524241:0.408154:0.008197:0.011738:0.012508:0.005703:0.012508:0.005503:0.003848:0.007466:0.005503:0.013143:0.011738:0.005503:0.003848:0.018049:0.013123:0.005711:0.012604:0.010660:0.012508:0.013181:0.005503:0.007466:0.011699:0.005792:0.010660:0.003848:0.010660:0.013143:0.003848:0.005515:0.005792:0.013143:0.006523:0.012508:0.005503:0.003848:0.006042:0.005503:0.006523:0.011738:0.012508:0.005494:0.006523:0.011699:0.006388
mour is completely excised. These children :@0.524241:0.440301:0.920506:0.440301:0.920506:0.424545:0.524241:0.424545:0.018049:0.012604:0.011699:0.005792:0.004331:0.003848:0.007466:0.004349:0.012450:0.012604:0.018049:0.013123:0.003848:0.012508:0.006523:0.012508:0.003848:0.010314:0.004349:0.012508:0.009236:0.012450:0.003848:0.007466:0.012508:0.013181:0.005330:0.004349:0.008197:0.011738:0.012508:0.007466:0.012508:0.004349:0.012450:0.011738:0.003848:0.003848:0.013181:0.005719:0.012508:0.011738:0.005330
often  suffer  long-term  effects,  ranging :@0.524241:0.456692:0.920488:0.456692:0.920488:0.440936:0.524241:0.440936:0.012604:0.006042:0.006523:0.012508:0.011738:0.005330:0.009637:0.007466:0.011699:0.006096:0.006042:0.012508:0.005792:0.005330:0.009642:0.003848:0.012604:0.011738:0.012950:0.006388:0.006523:0.012508:0.006313:0.018049:0.005330:0.009650:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.007466:0.005330:0.005330:0.009646:0.005792:0.013143:0.011738:0.012950:0.003848:0.011738:0.012950:0.005330
from  neurocognitive disability to  seizure :@0.524241:0.473083:0.920496:0.473083:0.920496:0.457327:0.524241:0.457327:0.006042:0.005711:0.012604:0.018049:0.005330:0.006396:0.011738:0.012508:0.011699:0.005711:0.012604:0.012450:0.012604:0.012939:0.011738:0.003848:0.006523:0.003848:0.010660:0.012508:0.011738:0.013181:0.003848:0.007466:0.013143:0.013123:0.003848:0.003848:0.003848:0.006546:0.010314:0.011738:0.006523:0.012604:0.005330:0.006394:0.007466:0.012508:0.003848:0.008178:0.011699:0.005713:0.012508:0.005330
disorders and stroke.:@0.524241:0.489474:0.714485:0.489474:0.714485:0.473718:0.524241:0.473718:0.013181:0.003848:0.007466:0.012604:0.005678:0.013181:0.012508:0.005792:0.007466:0.005330:0.013143:0.011738:0.013181:0.005330:0.007466:0.006523:0.005707:0.012604:0.009660:0.012508:0.005330
LYMPHOMAS:@0.524242:0.522839:0.670056:0.522839:0.670056:0.503243:0.524242:0.503243:0.010348:0.014581:0.021167:0.013170:0.015993:0.019756:0.021167:0.017404:0.012230
Children  can  develop  either  Hodgkin’s :@0.524242:0.541518:0.920483:0.541518:0.920483:0.525762:0.524242:0.525762:0.015644:0.011738:0.003848:0.003848:0.013181:0.005719:0.012508:0.011738:0.005330:0.007834:0.012450:0.013143:0.011738:0.005330:0.007836:0.013181:0.012508:0.010660:0.012508:0.003848:0.012604:0.013123:0.005330:0.007841:0.012508:0.003848:0.006523:0.011738:0.012508:0.005792:0.005330:0.007834:0.013143:0.012604:0.013181:0.012950:0.009660:0.003848:0.011738:0.006754:0.007466:0.005330
lymphoma (HL) or non-Hodgkin’s lympho-:@0.524242:0.557909:0.915144:0.557909:0.915144:0.542153:0.524242:0.542153:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.006388:0.007100:0.013143:0.008890:0.007100:0.006388:0.012604:0.005792:0.006375:0.011738:0.012604:0.011738:0.006388:0.013143:0.012604:0.013181:0.012950:0.009646:0.003848:0.011738:0.006754:0.007466:0.006388:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.006388
ma (NHL).:@0.524242:0.574300:0.616567:0.574300:0.616567:0.558544:0.524242:0.558544:0.018049:0.013143:0.005330:0.007100:0.014239:0.013143:0.008890:0.007100:0.005330
HODGKIN’S LYMPHOMA:@0.524242:0.607384:0.769262:0.607384:0.769262:0.589569:0.524242:0.589569:0.014539:0.017960:0.014966:0.017960:0.013256:0.005987:0.015822:0.005987:0.011118:0.005987:0.009407:0.013256:0.019242:0.011973:0.014539:0.017960:0.019242:0.015822
Hodgkin’s lymphoma usually presents in :@0.524242:0.624916:0.920474:0.624916:0.920474:0.609160:0.524242:0.609160:0.013143:0.012604:0.013181:0.012950:0.009660:0.003848:0.011738:0.006754:0.007466:0.011007:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.011007:0.011699:0.007466:0.011699:0.013143:0.003848:0.003848:0.010325:0.011007:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.007466:0.011007:0.003848:0.011738:0.005330
adolescence and is rare under five years :@0.524242:0.641307:0.920481:0.641307:0.920481:0.625551:0.524242:0.625551:0.013143:0.013181:0.012604:0.003848:0.012508:0.007466:0.012450:0.012508:0.011738:0.012450:0.012508:0.007214:0.013143:0.011738:0.013181:0.007218:0.003848:0.007466:0.007226:0.005792:0.013143:0.005711:0.012508:0.007214:0.011699:0.011738:0.013181:0.012508:0.005792:0.007210:0.004686:0.004686:0.010660:0.012508:0.007218:0.010314:0.012508:0.013143:0.005792:0.007466:0.005330
of age.  There is a male predominance :@0.524242:0.657698:0.920483:0.657688:0.920483:0.641932:0.524242:0.641942:0.012604:0.006042:0.008775:0.013143:0.012950:0.012508:0.005330:0.012423:0.008775:0.008197:0.011738:0.012508:0.005705:0.012508:0.008775:0.003848:0.007466:0.008775:0.013143:0.008775:0.018049:0.013143:0.003848:0.012508:0.008775:0.013123:0.005715:0.012508:0.013181:0.012604:0.018049:0.003848:0.011738:0.013143:0.011738:0.012450:0.012508:-0.394327
10:@0.595581:0.652069:0.608011:0.652069:0.608011:0.642883:0.595581:0.642883:0.006215:0.006215
and the tumour is  associated with in-:@0.524234:0.674078:0.915126:0.674078:0.915126:0.658323:0.524234:0.658323:0.013143:0.011738:0.013181:0.013662:0.006523:0.011738:0.012508:0.013662:0.006523:0.011699:0.018049:0.012594:0.011699:0.005792:0.013662:0.003848:0.007466:0.005330:0.008344:0.013143:0.007466:0.007466:0.012604:0.012450:0.003848:0.013143:0.006523:0.012508:0.013181:0.013662:0.015990:0.003848:0.006523:0.011738:0.013662:0.003848:0.011738:0.006388
creased family size and poor socio-eco-:@0.524234:0.690469:0.915172:0.690469:0.915172:0.674713:0.524234:0.674713:0.012450:0.005713:0.012508:0.013143:0.007466:0.012508:0.013181:0.009044:0.006042:0.013143:0.018049:0.003848:0.003848:0.010325:0.009044:0.007466:0.003848:0.008178:0.012508:0.009044:0.013143:0.011738:0.013181:0.009044:0.013123:0.012604:0.012604:0.005792:0.009044:0.007466:0.012604:0.012450:0.003848:0.012604:0.006388:0.012508:0.012450:0.012604:0.006388
nomic circumstances. Epstein-Barr virus :@0.524234:0.706860:0.920456:0.706860:0.920456:0.691104:0.524234:0.691104:0.011738:0.012604:0.018049:0.003848:0.012450:0.014759:0.012450:0.003848:0.005659:0.012450:0.011699:0.018049:0.007466:0.006523:0.013143:0.011738:0.012450:0.012508:0.007466:0.005330:0.014759:0.010314:0.013123:0.007466:0.006523:0.012508:0.003848:0.011738:0.006388:0.011045:0.013143:0.005792:0.005792:0.014759:0.010660:0.003848:0.005792:0.011699:0.007466:0.005330
infection is  a potential causative factor. :@0.524234:0.723251:0.920453:0.723251:0.920453:0.707495:0.524234:0.707495:0.003848:0.011738:0.006042:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.009871:0.003848:0.007466:0.005330:0.004555:0.013143:0.009871:0.013123:0.012604:0.006523:0.012508:0.011738:0.006523:0.003848:0.013143:0.003848:0.009871:0.012450:0.013143:0.011699:0.007466:0.013143:0.006523:0.003848:0.010660:0.012508:0.009871:0.006042:0.013143:0.012450:0.006523:0.012604:0.004372:0.005330:0.005330
The most common histology according :@0.524234:0.739642:0.920489:0.739642:0.920489:0.723886:0.524234:0.723886:0.008197:0.011738:0.012508:0.012103:0.018049:0.012604:0.007466:0.006523:0.012103:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.012103:0.011738:0.003848:0.007466:0.006523:0.012604:0.003848:0.012604:0.012950:0.010314:0.012103:0.013143:0.012450:0.012450:0.012604:0.005673:0.013181:0.003848:0.011738:0.012950:0.005330
to the WHO histological classification sys-:@0.524234:0.756033:0.915138:0.756033:0.915138:0.740277:0.524234:0.740277:0.006523:0.012604:0.007645:0.006523:0.011738:0.012508:0.007651:0.018473:0.013143:0.016722:0.007657:0.011738:0.003848:0.007466:0.006523:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.007655:0.012450:0.003848:0.013143:0.007466:0.007466:0.003848:0.004686:0.004686:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007660:0.007466:0.010314:0.007466:0.006388
tem is nodular sclerosis subtype, followed :@0.524234:0.772424:0.920472:0.772424:0.920472:0.756668:0.524234:0.756668:0.006523:0.012508:0.018049:0.007279:0.003848:0.007466:0.007293:0.011738:0.012604:0.013181:0.011699:0.003848:0.013143:0.005792:0.007277:0.007466:0.012450:0.003848:0.012508:0.005717:0.012604:0.007466:0.003848:0.007466:0.007293:0.007466:0.011699:0.013123:0.006523:0.010314:0.013123:0.012508:0.005330:0.007279:0.006042:0.012604:0.003848:0.003848:0.012604:0.015990:0.012508:0.013181:0.005330
by mixed cellularity subtype with nodular :@0.524234:0.788815:0.920491:0.788815:0.920491:0.773059:0.524234:0.773059:0.013123:0.010314:0.007601:0.018049:0.003848:0.009236:0.012508:0.013181:0.007591:0.012450:0.012508:0.003848:0.003848:0.011699:0.003848:0.013143:0.005792:0.003848:0.006523:0.010314:0.007601:0.007466:0.011699:0.013123:0.006523:0.010314:0.013123:0.012508:0.007601:0.015990:0.003848:0.006523:0.011738:0.007589:0.011738:0.012604:0.013181:0.011699:0.003848:0.013143:0.005792:0.005330
lymphocyte-predominant-,  lymphocyte-:@0.524234:0.805206:0.915144:0.805206:0.915144:0.789450:0.524234:0.789450:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.012450:0.010314:0.006523:0.012508:0.006388:0.013123:0.005715:0.012508:0.013181:0.012604:0.018049:0.003848:0.011738:0.013143:0.011738:0.006523:0.006388:0.005330:0.005330:0.015971:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.012450:0.010314:0.006523:0.012508:0.006388
rich- and lymphocyte-depleted subtypes :@0.524234:0.821597:0.920474:0.821597:0.920474:0.805841:0.524234:0.805841:0.005792:0.003848:0.012450:0.011738:0.006388:0.008390:0.013143:0.011738:0.013181:0.008390:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.012450:0.010314:0.006523:0.012508:0.006388:0.013181:0.012508:0.013123:0.003848:0.012508:0.006523:0.012508:0.013181:0.008390:0.007466:0.011699:0.013123:0.006523:0.010314:0.013123:0.012508:0.007466:0.005330
being rare. Clinically, patients present with :@0.524234:0.837988:0.920483:0.837988:0.920483:0.822232:0.524234:0.822232:0.013123:0.012508:0.003848:0.011738:0.012950:0.004772:0.005792:0.013143:0.005711:0.012508:0.005330:0.004762:0.015644:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.005330:0.004786:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.004772:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.004762:0.015990:0.003848:0.006523:0.011738:0.005330
enlarged lymph nodes in the neck, axilla, :@0.524234:0.854379:0.920466:0.854379:0.920466:0.838623:0.524234:0.838623:0.012508:0.011738:0.003848:0.013143:0.005807:0.012950:0.012508:0.013181:0.006700:0.003848:0.010314:0.018049:0.013123:0.011738:0.006716:0.011738:0.012604:0.013181:0.012508:0.007466:0.006700:0.003848:0.011738:0.006704:0.006523:0.011738:0.012508:0.006698:0.011738:0.012508:0.012450:0.009660:0.005330:0.006694:0.013143:0.009236:0.003848:0.003848:0.003848:0.013143:0.005330:0.005330
groin or with lymph nodes in the mediasti-:@0.524234:0.870770:0.915144:0.870770:0.915144:0.855014:0.524234:0.855014:0.012950:0.005709:0.012604:0.003848:0.011738:0.005954:0.012604:0.005792:0.005946:0.015990:0.003848:0.006523:0.011738:0.005956:0.003848:0.010314:0.018049:0.013123:0.011738:0.005965:0.011738:0.012604:0.013181:0.012508:0.007466:0.005952:0.003848:0.011738:0.005965:0.006523:0.011738:0.012508:0.005948:0.018049:0.012508:0.013181:0.003848:0.013143:0.007466:0.006523:0.003848:0.006388
num. They may also have lost weight in the :@0.524234:0.887161:0.920485:0.887161:0.920485:0.871405:0.524234:0.871405:0.011738:0.011699:0.018049:0.005330:0.004289:0.008197:0.011738:0.012508:0.010314:0.004297:0.018049:0.013143:0.010314:0.004297:0.013143:0.003848:0.007466:0.012604:0.004310:0.011738:0.013143:0.010660:0.012508:0.004299:0.003848:0.012604:0.007466:0.006523:0.004297:0.015990:0.012508:0.003848:0.012950:0.011738:0.006523:0.004291:0.003848:0.011738:0.004299:0.006523:0.011738:0.012508:0.005330
preceding  six months,  unexplained fever :@0.524234:0.903552:0.920493:0.903552:0.920493:0.887796:0.524234:0.887796:0.013123:0.005715:0.012508:0.012450:0.012508:0.013181:0.003848:0.011738:0.012950:0.005330:0.003371:0.007466:0.003848:0.009236:0.008717:0.018049:0.012604:0.011738:0.006523:0.011738:0.007466:0.005330:0.005330:0.003364:0.011699:0.011738:0.012508:0.009236:0.013123:0.003848:0.013143:0.003848:0.011738:0.012508:0.013181:0.008717:0.006042:0.012508:0.010660:0.012508:0.005792:0.005330
of more than 38°C, fatigue and drenching :@0.524234:0.919943:0.920485:0.919943:0.920485:0.904187:0.524234:0.904187:0.012604:0.006042:0.004936:0.018049:0.012604:0.005709:0.012508:0.004945:0.006523:0.011738:0.013143:0.011738:0.004936:0.010660:0.010660:0.007697:0.015644:0.005330:0.004936:0.006042:0.013143:0.006523:0.003848:0.012950:0.011699:0.012508:0.004936:0.013143:0.011738:0.013181:0.004945:0.013181:0.005713:0.012508:0.011738:0.012450:0.011738:0.003848:0.011738:0.012950:0.005330
night  sweats,  classified  as  “B”  symptoms. :@0.524234:0.936333:0.920466:0.936333:0.920466:0.920578:0.524234:0.920578:0.011738:0.003848:0.012950:0.011738:0.006523:0.005330:0.003231:0.007466:0.015990:0.012508:0.013143:0.006523:0.007466:0.005330:0.005330:0.003235:0.012450:0.003848:0.013143:0.007466:0.007466:0.003848:0.004686:0.004686:0.012508:0.013181:0.005330:0.003250:0.013143:0.007466:0.005330:0.003242:0.009660:0.011045:0.009313:0.005330:0.003237:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.007466:0.005330:0.005330